The patient was informed his lifetime risk of developing cancer may be lower than someone who is heterozygous for a BMPR1A pathogenic variant; however, the percent mosaicism in other tissues (i.e., colorectum and stomach) is unknown. The gene discussed is BMPR1A; the disease is cancer.